The purification and unique carbohydrate binding properties, including blood group B-specific agglutination and preferential binding to Gal␣1,3Gal-containing sugar epitopes, of the Marasmius oreades agglutinin (MOA) are reported in an accompanying paper (Winter, H. C., Mostafapour, K., and Goldstein, I. J. (2002) J. Biol. Chem. 277, 14996 -15001). Here we describe the cloning, characterization, and expression of MOA. MOA was digested with trypsin and endoproteinase Asp-N, and the peptide fragments were purified by high performance liquid chromatography. Amino acid sequence data were obtained for eight peptides. Using oligonucleotides deduced from the peptide sequences for a reverse transcriptase-PCR, a 41-base pair cDNA was obtained. The 41-base pair fragment allowed the generation a fulllength cDNA using 5 and 3 rapid amplification of cDNA ends. MOA cDNA encodes a protein of 293 amino acids that contains a ricin domain. These carbohydrate binding domains were first described in subunits of bacterial toxins and are also commonly found in polysaccharidedegrading enzymes. Whereas these proteins are known to display a variety of sugar binding specificities, none to date are known to share MOA's high affinity for Gal␣1,3Gal and Gal␣1,3Gal1,4GlcNAc. Recombinantly expressed and purified MOA retains the specificity and affinity observed with the native protein. This study provides the basis for analyzing the underlying cause for the unusual binding specificity of MOA.Specificity varies greatly among carbohydrate-binding proteins. Whereas some lectins broadly recognize all oligosaccharides containing particular terminal sugars, others show increasing affinity for specific di-and trisaccharides. Fewer still show almost no reactivity with a given sugar monomer yet bind strongly and specifically to particular oligosaccharides (1). As described in the accompanying paper (2), the Marasmius oreades agglutinin (MOA) 1 binds to Gal␣1,3Gal-containing sugars and falls into this last category.The Gal␣1,3Gal epitope has received considerable attention, stemming from its presence in the glycoproteins of most mammals and its conspicuous absence in humans, apes, and Old World monkeys (3). This absence is attributable to lack of the specific ␣1,3-galactosyltransferase because of frameshift mutations in its gene (4). The resulting immunogenicity of the Gal␣1,3Gal epitope is a significant barrier to xenotransplantation (5). Despite the importance of Gal␣1,3Gal epitope recognition, MOA is currently the only lectin known to have exclusive specificity for this disaccharide (2).Few proteins have been shown to bind with any specificity to Gal␣1,3Gal. While Clostridium difficile toxin A and antibodies recognizing the ␣-galactosyl epitope both bind well to some Gal␣1,3Gal-containing oligosaccharides (6), the size and species of origin of MOA suggest that it is fundamentally dissimilar to these proteins. On these grounds, the blood group Bspecific Griffonia simplicifolia I-B 4 isolectin is perhaps more appropriate for comparison (7). A recent x...